Artificial Intelligence and Genomics Accelerate the Fight Against Superbugs with New Antibiotics and Rapid Diagnostics

Superbugs are among the greatest threats to global health. The excessive and inappropriate use of antibiotics accelerates the evolution of resistant microorganisms, turning infections that were previously simple to treat into potentially fatal diseases. This scenario drives an urgent search for new diagnostic and treatment solutions, and it is in this context that artificial intelligence (AI) and genomic analysis stand out as transformative tools.

The report from Fantástico (Click to see) shows how AI is accelerating the discovery of new antibiotics against superbugs. Based on data analysis and machine learning, this approach drastically reduces the time and cost of drug development, which traditionally takes decades and billions of dollars.

Complementarily, Biofy Genomics is applying AI on another front, through the Abby Recommender. While MIT uses the technology to identify new antibiotics in the laboratory, Biofy bets on precision medicine, offering rapid diagnostics and personalized treatments. The Abby Recommender integrates AI and metagenomics of bacteria, replacing the wait of several days for culture results with a genetic analysis completed in a few hours.

With this process, the platform can:

* Accurately identify the microorganism.

* Map resistance genes present in the bacteria.

* Indicate the most effective antibiotics, avoiding the use of ineffective medications.

By shortening the diagnostic time from days to hours, the Abby Recommender enables quick and accurate medical decisions, increasing the chances of treatment success. In addition, it contributes to the fight against antimicrobial resistance, as it reduces the indiscriminate use of antibiotics.

The report from Fantástico and the work of Biofy Genomics represent two sides of the same strategy against superbugs. On one side, AI paves the way for the antibiotics of the future; on the other, biotechnology puts AI to work in the present, ensuring faster diagnoses and tailored treatments.

Check out the complete article from Fantástico - Credits: TV Globo/ G1